Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report
Brigitte Bader‐Meunier, Alice Hadchouel, Laureline Berteloot, Laura Polivka, Vivien Béziat, Jean‐Laurent Casanova, Romain Lévy
Topics & Concepts
MedicineMacrophage activation syndromeCanakinumabTocilizumabPrednisoneArthritisInternal medicineLeukocytosisInterstitial lung diseasePediatricsRefractory (planetary science)DiseaseSurgeryAnakinraLungAstrobiologyPhysicsAutoimmune and Inflammatory Disorders ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisImmunodeficiency and Autoimmune Disorders